We are live on ! Find out more
OA

Oak Associates Portfolio holdings

AUM $1.49B
1-Year Est. Return 34.25%
This Fund
S&P 500
This Quarter Est. Return
+1.69%
1 Year Est. Return
+34.25%
3 Year Est. Return
+111.6%
5 Year Est. Return
+123.41%
10 Year Est. Return
+571.62%
AUM
$831M
AUM Growth
-$4.54M
Cap. Flow
-$10.5M
Cap. Flow %
-1.26%
Top 10 Hldgs %
36.28%
Holding
191
New
7
Increased
31
Reduced
36
Closed
13

Top Buys

Rank Stock Value
1
XLNX
Xilinx Inc
XLNX
+$15.1M
2
PH icon
Parker-Hannifin
PH
+$2.33M
3
SIMO icon
Silicon Motion
SIMO
+$1.54M
4
MDT icon
Medtronic
MDT
+$1.5M
5
BRCM
BROADCOM CORP CL-A
BRCM
+$1.3M

Top Sells

Rank Stock Value
1
SYK icon
Stryker
SYK
+$11.6M
2
XOM icon
ExxonMobil
XOM
+$10.7M
3
VC icon
Visteon
VC
+$2.5M
4
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$2.34M
5
BFH icon
Bread Financial
BFH
+$1.88M

Sector Composition

Rank Sector Weight
1 Technology 35.7%
2 Financials 22.62%
3 Healthcare 16.77%
4 Communication Services 6.86%
5 Consumer Discretionary 3.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EG icon
76
Everest Group
EG
$15.2B
$2.56M 0.31%
14,702
– –
IPG
77
DELISTED
Interpublic Group of Companies
IPG
$2.51M 0.3%
113,650
+550
+0.5% +$11.7K
RDS.A
78
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$2.42M 0.29%
40,629
+180
+0.4% +$11.4K
EPC icon
79
Edgewell Personal Care
EPC
$1.27B
$2.4M 0.29%
23,405
-2,833
-11% -$281K
CI icon
80
Cigna
CI
$76.6B
$2.36M 0.28%
18,200
– –
NVS icon
81
Novartis
NVS
$295B
$2.33M 0.28%
26,338
– –
GSBC icon
82
Great Southern Bancorp
GSBC
$863M
$2.31M 0.28%
58,720
– –
CRL icon
83
Charles River Laboratories
CRL
$10.9B
$2.21M 0.27%
27,900
– –
BHI
84
DELISTED
Baker Hughes
BHI
$2.2M 0.26%
34,550
-1,110
-3% -$67K
ACH
85
Accendra Health
ACH
$240M
$2.19M 0.26%
64,600
– –
JNJ icon
86
Johnson & Johnson
JNJ
$635B
$2.18M 0.26%
21,700
– –
SYK icon
87
Stryker
SYK
$127B
$2.18M 0.26%
23,600
-124,320
-84% -$11.6M
LLY icon
88
Eli Lilly
LLY
$1.07T
$2.14M 0.26%
29,400
-1,500
-5% -$107K
AVG
89
DELISTED
AVG Technologies N.V.
AVG
$1.99M 0.24%
91,700
– –
AMBA icon
90
Ambarella
AMBA
$2.99B
$1.97M 0.24%
25,975
-7,950
-23% -$483K
ZBH icon
91
Zimmer Biomet
ZBH
$17.7B
$1.96M 0.24%
17,201
– –
PDCO
92
DELISTED
Patterson Companies, Inc.
PDCO
$1.87M 0.23%
38,400
– –
UNH icon
93
UnitedHealth
UNH
$382B
$1.83M 0.22%
15,500
– –
GSK icon
94
GSK
GSK
$103B
$1.74M 0.21%
30,240
– –
MCK icon
95
McKesson
MCK
$98.5B
$1.71M 0.21%
7,550
– –
SNY icon
96
Sanofi
SNY
$104B
$1.64M 0.2%
33,200
– –
DGX icon
97
Quest Diagnostics
DGX
$25.1B
$1.64M 0.2%
21,300
– –
ILMN icon
98
Illumina
ILMN
$29.4B
$1.63M 0.2%
9,036
-566
-6% -$107K
OCR
99
DELISTED
OMNICARE INC
OCR
$1.63M 0.2%
21,100
-800
-4% -$60.8K
SIMO icon
100
Silicon Motion
SIMO
$9.19B
$1.51M 0.18%
+56,300
New +$1.54M
2 3
4
5 6

Similar funds

FAT
First American Trust Santa Ana, California $1.49B AUM 21.98% 1-Year Est. Return
AIA
Ally Invest Advisors Charlotte, North Carolina $1.49B AUM 14.08% 1-Year Est. Return
LFS
Lutz Financial Services Omaha, Nebraska $1.49B AUM 10.4% 1-Year Est. Return
PIM
Plato Investment Management Sydney, NSW, Australia $1.49B AUM 28.65% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
RIM
Rush Island Management New York $1.49B AUM 4.65% 1-Year Est. Return
SB
Simmons Bank Pine Bluff, Arkansas $1.49B AUM 23.32% 1-Year Est. Return
MHS
M Holdings Securities Portland, Oregon $1.48B AUM 26.15% 1-Year Est. Return

Oak Associates's Q1 2015 Portfolio in Review

As of Q1 2015, Oak Associates held 191 positions worth $831M, down 0.54% from $836M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Oak Associates's Q1 2015 filing shows 7 new, 31 increased, 36 reduced and 13 closed positions. Its largest new stake was Silicon Motion: 56,300 shares worth $1.51M. The largest sale was Stryker, an estimated $11.6M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.

  • Oak Associates's largest Q1 2015 buy was Silicon Motion: 56,300 shares worth $1.51M.
  • Oak Associates added most to Xilinx Inc in Q1 2015, an estimated $15.1M increase.
  • Oak Associates's biggest Q1 2015 reduction was Stryker, cutting an estimated $11.6M.
  • Oak Associates fully exited Visteon in Q1 2015, selling an estimated $2.5M.
  • Oak Associates's ten largest holdings make up 36% of its $831M portfolio in Q1 2015.
  • Oak Associates opened 7 new positions and closed 13 in Q1 2015.
  • Oak Associates's portfolio value fell 0.54% quarter-over-quarter to $831M.

Based on Oak Associates's 13F filing for Q1 2015, filed 11 May 2015.